Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Higher levels of β-carotene and vitamin E may help prevent certain types of hair loss.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Early hair loss in men may signal broader health issues similar to PCOS in women.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Skin changes in obesity can indicate metabolic issues but aren't reliable for assessing risk or monitoring treatment.

Using enzymes with laser hair removal may reduce unwanted hair growth better than laser alone.

Most people in Jazan know about vitamin D, zinc, and ferritin's link to hair loss but don't practice enough preventive measures.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Combining LFQS and IPL is more effective and faster for treating melasma than LFQS alone.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Early hair loss may signal metabolic issues but doesn't predict diabetes.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Androgen use may increase the risk of stroke, but more research is needed.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Vitiligo and alopecia areata may have similar causes despite their differences.

PCOS should be reclassified into two types based on hormone levels and symptoms.

The Tyrolean Iceman had mostly Anatolian farmer ancestry and traits like darker skin and a risk for certain health issues.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Schizophrenia risk genes may affect early brain development, contributing to the disease.

The risks of testosterone implants in women outweigh the benefits.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.